At a glance
ClinicalIndex Comparison Record- ✓Admitted with COPD exacerbation as primary diagnosis
- ✓Produces >15 mL/day of sputum subjectively
- ✓Subjective difficulty clearing secretions
- ✓Physician exam with coarse ronchi suggesting impacted secretions
- ✕Cannot use flutter device or follow commands
- ✕Altered mental status
- ✕Active malignancy or non-COPD primary diagnosis
- ✕Severe exacerbation (intubated, continuous NIV, unable to speak full sentences)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vibratory/Positive Expiratory Pressure Device and Hospital Length of Stay for Acute Exacerbation of Chronic Obstructive Pulmonary Disease
In Brief
A clinical study evaluating Acapella Vibratory PEP Therapy Device plus usual care and Sham Acapella Vibratory PEP Device plus usual care for Chronic Obstructive Pulmonary Disease. Completed, enrolled 91 participants across 1 site.
Detailed Summary
This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.
Study Details
Timeline
Interventions
The acapella® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.
The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.